Guardion Health Sciences is a drug manufacturers - specialty & generic business based in the US. Guardion Health Sciences shares (GHSI) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.27 – a decrease of 6.57% over the previous week. Guardion Health Sciences employs 9 staff and has a trailing 12-month revenue of around $12.2 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $3.27 |
|---|---|
| 52-week range | $1.64 - $7.45 |
| 50-day moving average | $9.41 |
| 200-day moving average | $8.53 |
| Wall St. target price | $40.00 |
| PE ratio | N/A |
| Dividend yield | $0 (174.67%) |
| Earnings per share (TTM) | $-4.11 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $3.27 from 2024-10-09
| 1 week (2024-10-03) | -6.57% |
|---|---|
| 1 month (2024-09-10) | -66.70% |
| 3 months (2024-07-10) | -67.00% |
| 6 months (2024-04-10) | -58.61% |
| 1 year (2023-10-10) | -53.08% |
|---|---|
| 2 years (2022-10-10) | 2,116.95% |
| 3 years (2021-10-08) | 202.78% |
| 5 years (2019-10-10) | 3.486 |
| Revenue TTM | $12.2 million |
|---|---|
| Gross profit TTM | $4.5 million |
| Return on assets TTM | -15.53% |
| Return on equity TTM | -50.26% |
| Profit margin | 52.13% |
| Book value | $10.71 |
| Market Capitalization | $4.2 million |
TTM: trailing 12 months
Dividend payout ratio: 1.9% of net profits
Recently Guardion Health Sciences has paid out, on average, around 1.9% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 174.67% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Guardion Health Sciences shareholders could enjoy a 174.67% return on their shares, in the form of dividend payments. In Guardion Health Sciences's case, that would currently equate to about $0 per share.
While Guardion Health Sciences's payout ratio might seem low, this can signify that Guardion Health Sciences is investing more in its future growth.
Guardion Health Sciences's most recent dividend payout was on 22 September 2024. The latest dividend was paid out to all shareholders who bought their shares by 23 September 2024 (the "ex-dividend date").
Guardion Health Sciences's shares were split on a 1:50 basis on 8 January 2023. So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Guardion Health Sciences shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for Guardion Health Sciences shares which in turn could have impacted Guardion Health Sciences's share price.
Over the last 12 months, Guardion Health Sciences's shares have ranged in value from as little as $1.6368 up to $7.452. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Guardion Health Sciences's is 0.708. This would suggest that Guardion Health Sciences's shares are less volatile than average (for this exchange).
Guardion Health Sciences, Inc. , a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth. com. Guardion Health Sciences, Inc.
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
These are the stocks to buy when you don’t have much to spend.
Explore the best bonuses for opening a new brokerage account.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out the best-performing ETFs so far in 2024.
Read our beginner’s guide to trading options in the US.